Literature DB >> 12031064

Drug-induced prolongation of the QT interval: why the regulatory concern?

Rashmi R Shah1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12031064     DOI： 10.1046/j.1472-8206.2002.00082.x

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN： 0767-3981            Impact factor:   2.748


× No keyword cloud information.
  9 in total

1.  Moving towards better predictors of drug-induced torsades de pointes.

Authors:  A S Bass; B Darpo; J-P Valentin; P Sager; K Thomas
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

Review 2.  The thorough QT/QTc study 4 years after the implementation of the ICH E14 guidance.

Authors:  Borje Darpo
Journal:  Br J Pharmacol       Date:  2009-11-18       Impact factor: 8.739

3.  Implications of the IQ-CSRC Prospective Study: Time to Revise ICH E14.

Authors:  Borje Darpo; Christine Garnett; James Keirns; Norman Stockbridge
Journal:  Drug Saf       Date:  2015-09       Impact factor: 5.606

4.  Effects of prulifloxacin on cardiac repolarization in healthy subjects: a randomized, crossover, double-blind versus placebo, moxifloxacin-controlled study.

Authors:  Maria Teresa Rosignoli; Giorgio Di Loreto; Paolo Dionisio
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

5.  A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors.

Authors:  Thierry Lesimple; Julien Edeline; Timothy J Carrothers; Frédérique Cvitkovic; Borje Darpo; Jean-Pierre Delord; Hervé Léna; Nicolas Penel; Geoff J Edwards; Kenneth Law; Jantien Wanders; Allan Kristensen; Larisa Reyderman
Journal:  Invest New Drugs       Date:  2012-11-11       Impact factor: 3.850

6.  Modelling of drug-induced QT-interval prolongation: estimation approaches and translational opportunities.

Authors:  Eleonora Marostica; Karel Van Ammel; Ard Teisman; Koen Boussery; Jan Van Bocxlaer; Filip De Ridder; David Gallacher; An Vermeulen
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-11       Impact factor: 2.745

Review 7.  Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 8.  Pharmacogenetics of Drug-Induced QT Interval Prolongation: An Update.

Authors:  Maartje N Niemeijer; Marten E van den Berg; Mark Eijgelsheim; Peter R Rijnbeek; Bruno H Stricker
Journal:  Drug Saf       Date:  2015-10       Impact factor: 5.606

Review 9.  Clinical Trials in a Dish: A Perspective on the Coming Revolution in Drug Development.

Authors:  Bernard Fermini; Shawn T Coyne; Kevin P Coyne
Journal:  SLAS Discov       Date:  2018-06-04       Impact factor: 3.341
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.